Brief: Medifast Names Nicholas Johnson President, Expected To Succeed Dan Chard As CEO In June 2026
05/01/2026 14:18
Jan 5 (Reuters) - Medifast Inc MED.N: MEDIFAST ANNOUNCES PLANNED LEADERSHIP TRANSITION MEDIFAST INC: NICHOLAS JOHNSON APPOINTED PRESIDENT, AND EXPECTED TO SUCCEED DAN CHARD AS CEO IN JUNE 2026; CHARD TO REMAIN CHAIRMAN Source text: ID:nBwbZCSrNa Further company coverage: MED.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medifast
See all newsMedifast Inc reports results for the quarter ended June 30 - Earnings Summary
Medifast Q2 revenue falls 28% as active coaches drop
Brief: Medifast Q2 Revenue USD 76.384 Million
Medifast Inc expected to post a loss of 65 cents a share - Earnings Preview
Brief: Medifast Confirms Appointment Of Nicholas Johnson As Chief Executive Officer